期刊文献+

纯化的自体外周血造血干细胞移植治疗难治性幼年型类风湿性关节炎的初步研究 被引量:5

Study of purified autologous peripheral blood stem cell transplantation in treatment of patients with refractory juvenile rheumatoid arthritis
暂未订购
导出
摘要 目的探索采用纯化的自体外周血造血干细胞移植治疗难治性幼年型类风湿性关节炎的临床效果。方法对3例难治性幼年型类风湿性关节炎患者进行纯化的CD34+细胞移植,动员得到外周血单个核细胞分别为8.23×108/kg、11.94×108/kg和9.32×108/kg;经CliniMACS CD34+细胞分选仪分选后得到CD34+细胞数分别为7.32×106/kg、8.75×106/kg和5.37×106/kg。采用BEAM+ATG预处理方案。结果发热的2例患者体温均降至正常,大关节肿痛均完全消失,四肢活动自如,血沉、C反应蛋白、类风湿因子各项指标正常,随访中疾病仍呈稳定状态。结论采用纯化的自体外周血造血干细胞移植可使患者造血功能得到较快重建,近期临床症状改善,是有效和安全的。 Objective To explore the clinical effect of purified autologous peripheral blood stem cell transplantation in treatment of patients with refractory juvenile rheumatoid arthritis(JRA).Methods Three cases of refractory juvenile rheumatoid arthritis in patients with purified CD34+cell transplantation,mobilized peripheral blood mononuclear cells obtained were 8.23×108/kg,11.94×108/kg and 9.32×108/kg.The CliniMACS CD34+cell sorter sorting CD34+cells obtained was 7.32×106/kg,8.75 ×106/kg and 5.37×106/kg.BEAM+ATG conditioning regimen used.Results The 2 patients with fever were reduced to normal temperature,large joint swelling and pain are completely gone,limbs move freely,erythrocyte sedimentation rate(ESR),C reactive protein(CRP),rheumatoid factor(RF)indicators normal,During follow-up,the disease continued to show a steady state.Conclusion The purified autologous peripheral blood stem cell transplantation in patients with hematopoietic function can be rapidly rebuilt,and improvement of clinical symptoms,is effective and safe.
出处 《实用医院临床杂志》 2011年第4期33-34,共2页 Practical Journal of Clinical Medicine
关键词 自体外周血造血干细胞移植 难治性 类风湿性关节炎 幼儿 Autologous peripheral blood stem cell transplantation Refractoriness Rheumatoid arthritis Juvenile
  • 相关文献

参考文献2

二级参考文献10

  • 1Tyndall A, Grotwohl A. Immune ablation and stem-cell therapy in autoimmune disease clinical experience. Arthritis Res, 2000, 2: 276-280.
  • 2Bombradier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI, a disease activity index for lupus patients. Arthritis Rheum, 1992, 35: 630-640.
  • 3Flson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum, 1993, 36: 729-740.
  • 4Prevoo ML, Van′t Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum, 1995, 38: 44-48.
  • 5Leng XM, Zhao Y, Zhou DB, et al. Study of treatment of refractory rheumatoid arthritis with autologous peripheral blood stem cell transplantation. Natl Med J China, 2002, 82: 748-751.冷晓梅,赵岩,周道斌,等. 自体外周血干细
  • 6Adachi Y, Inaba M, Amoh Y, et al. Effect of bone marrow transplantation on antiphospholipid antibody syndrome in murine lupus mice. Immunobiology, 1995, 192: 218-230.
  • 7Verburg RJ, Kruize AA, van den Hoogen FH, et al. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis. Arthritis Rheum, 2001, 44: 754-760.
  • 8van Laar JM. Immune ablation and stem cell therapy in autoimmune disease: immunological reconstitution after high-dose immunosuppression and hematopoietic stem cell transplantation. Arthritis Res, 2000, 2: 270-275.
  • 9Pavletic SZ, Odell JR, Pirruccello SJ, et al. Intensive immunoablation and autologous blood cell transplantation in patients with refracrtory rheumatoid arthritis: the University of Nebraska experience. J Rheumatol, 2001, 28 (Suppl 64):13-20.
  • 10Bingham SJ, Snowden J, McGonagle D, et al. Autologous stem cell transplantation for rheumatoid arthritis-interim report of 6 patients. J Rheumatol, 2001, 28(Suppl 64): 21-24.

共引文献19

同被引文献39

  • 1Xu J,Wang D,Liu D,et al.Allogeneic mesenchymal stem cell treatmentalleviates experimental and clinical Sjogren syndrome [J].Blood,2012,120(15):3142-3151.
  • 2Dazzi F,Krampera M.Mesenchymal stem cells and autoimmune diseases[J].Best Pract Res Clin Haematol,2011,24(1):49-57.
  • 3Scherer HU,van Pel M,Toes RE,et al.Mesenchymal stem cells inautoimmune diseases:hype or hope?[J].Arthritis Res Ther,2010,12(3):126.
  • 4Liang J,Li X,Zhang H,et al.Allogeneic mesenchymal stem cellstransplantation in patients with refractory RA [J].Clin Rheumatol,2012,31(1):157-161.
  • 5De Miguel MP,Fuentes-Juliá n S,Blá zquez-Martí nez A,et al.Immunosuppressive properties of mesenchymal stem cells:advancesand applications[J].Curr Mol Med,2012,12(5):574-591.
  • 6Daikeler T,Tyndall A.Stemcell treatment of autoimmune disease[J].Dtsch Med Wochenschr,2011,136(33):1684-1686.
  • 7Kraus KH,Kirker-Head C.Mesenchymal stem cells and bone regeneration[J].Vet Surg,2006,35(3):232-242.
  • 8Bielby R,Jones E,McGonagle D.The role of mesenchymal stemcells in maintenance and repair of bone[J].Injury,2007,38(Suppl 1):S26-32.
  • 9Li X,Liu L,Meng D,et al.Enhanced apoptosis and senescence ofbone-marrow-derived mesenchymal stem cells in patients with systemiclupus erythematosus [J].Stem Cells Dev,2012,21(13):2387-2394.
  • 10Liang J,Zhang H,Hua B,et al.Allogenic mesenchymal stem cellstransplantation in refractory systemic lupus erythematosus:a pilotclinical study[J].Ann RheumDis,2010,69(8):1423-1429.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部